Characterising nitric oxide-mediated metabolic benefits of low-dose ultraviolet radiation in the mouse: a focus on brown adipose tissue.


Journal

Diabetologia
ISSN: 1432-0428
Titre abrégé: Diabetologia
Pays: Germany
ID NLM: 0006777

Informations de publication

Date de publication:
01 2020
Historique:
received: 21 03 2019
accepted: 29 08 2019
pubmed: 13 11 2019
medline: 28 11 2020
entrez: 13 11 2019
Statut: ppublish

Résumé

Exposure to sunlight has the potential to suppress metabolic dysfunction and obesity. We previously demonstrated that regular exposure to low-doses of ultraviolet radiation (UVR) reduced weight gain and signs of diabetes in male mice fed a high-fat diet, in part via release of nitric oxide from skin. Here, we explore further mechanistic pathways through which low-dose UVR exerts these beneficial effects. We fed mice with a luciferase-tagged Ucp1 gene (which encodes uncoupling protein-1 [UCP-1]), referred to here as the Ucp1 luciferase transgenic mouse ('Thermomouse') a high-fat diet and examined the effects of repeated exposure to low-dose UVR on weight gain and development of metabolic dysfunction as well as UCP-1-dependent thermogenesis in interscapular brown adipose tissue (iBAT). Repeated exposure to low-dose UVR suppressed the development of glucose intolerance and hepatic lipid accumulation via dermal release of nitric oxide while also reducing circulating IL-6 (compared with mice fed a high-fat diet only). Dietary nitrate supplementation did not mimic the effects of low-dose UVR. A single low dose of UVR increased UCP-1 expression (by more than twofold) in iBAT of mice fed a low-fat diet, 24 h after exposure. However, in mice fed a high-fat diet, there was no effect of UVR on UCP-1 expression in iBAT (compared with mock-treated mice) when measured at regular intervals over 12 weeks. More extensive circadian studies did not identify any substantial shifts in UCP-1 expression in mice exposed to low-dose UVR, although skin temperature at the interscapular site was reduced in UVR-exposed mice. The appearance of cells with a white adipocyte phenotype ('whitening') in iBAT induced by consuming the high-fat diet was suppressed by exposure to low-dose UVR in a nitric oxide-dependent fashion. Significant shifts in the expression of important core gene regulators of BAT function (Dio2, increased more than twofold), fatty acid transport (increased Fatp2 [also known as Slc27a2]), lipolysis (decreased Atgl [also known as Pnpla2]), lipogenesis (decreased Fasn) and inflammation (decreased Tnf), and proportions of macrophages (increased twofold) were observed in iBAT of mice exposed to low-dose UVR. These effects were independent of nitric oxide released from skin. Our results suggest that non-burning (low-dose) UVR suppresses the BAT 'whitening', steatotic and pro-diabetic effects of consuming a high-fat diet through skin release of nitric oxide, with some metabolic and immune pathways in iBAT regulated by UVR independently of nitric oxide.

Identifiants

pubmed: 31713010
doi: 10.1007/s00125-019-05022-5
pii: 10.1007/s00125-019-05022-5
doi:

Substances chimiques

Blood Glucose 0
Uncoupling Protein 1 0
Nitric Oxide 31C4KY9ESH

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

179-193

Références

Int J Obes (Lond). 2013 Jun;37(6):853-60
pubmed: 22964790
Obesity (Silver Spring). 2012 Jul;20(7):1527-9
pubmed: 22447290
Cell Rep. 2014 Dec 11;9(5):1584-1593
pubmed: 25466254
Cell Rep. 2017 Sep 12;20(11):2678-2692
pubmed: 28903047
J Invest Dermatol. 2009 Apr;129(4):834-42
pubmed: 18818674
Antioxid Redox Signal. 2012 Aug 1;17(3):422-32
pubmed: 22133018
J Invest Dermatol. 2014 Jul;134(7):1839-1846
pubmed: 24445737
Cell Metab. 2009 Feb;9(2):203-9
pubmed: 19187776
Cell Metab. 2016 Apr 12;23(4):602-9
pubmed: 26972823
Photochem Photobiol Sci. 2017 Mar 16;16(3):362-373
pubmed: 28009891
J Lipid Res. 2018 May;59(5):784-794
pubmed: 29599420
Diabetes. 2015 Feb;64(2):471-484
pubmed: 25249574
Biochimie. 2017 Mar;134:28-34
pubmed: 27984203
J Endocrinol. 2017 Apr;233(1):81-92
pubmed: 28154004
Cell Rep. 2018 Mar 27;22(13):3521-3533
pubmed: 29590620
J Clin Invest. 2013 Jan;123(1):215-23
pubmed: 23221344
J Exp Biol. 2018 Mar 7;221(Pt Suppl 1):
pubmed: 29514884
Front Physiol. 2017 Jul 31;8:520
pubmed: 28824441
PLoS One. 2015 Mar 13;10(3):e0119784
pubmed: 25768847
BMC Res Notes. 2019 Feb 11;12(1):78
pubmed: 30744663
Diabetes. 2014 Nov;63(11):3759-69
pubmed: 25342734
J Immunol. 2017 Apr 1;198(7):2927-2934
pubmed: 28193830
Proc Natl Acad Sci U S A. 2001 Oct 23;98(22):12814-9
pubmed: 11606734
Acta Physiol (Oxf). 2014 Mar;210(3):498-507
pubmed: 24716231
J Dermatol Sci. 2007 Sep;47(3):241-3
pubmed: 17572071
Am J Physiol Endocrinol Metab. 2019 May 1;316(5):E729-E740
pubmed: 30807213
Essays Biochem. 2010;47:53-67
pubmed: 20533900
Am J Physiol. 1989 Jun;256(6 Pt 1):E773-9
pubmed: 2500023
Neurosci Lett. 2019 Mar 23;696:225-232
pubmed: 30586638
Int J Mol Sci. 2012 Dec 21;14(1):191-204
pubmed: 23344028
PLoS One. 2017 Mar 13;12(3):e0173661
pubmed: 28288167
PLoS One. 2012;7(9):e46006
pubmed: 23049920
J Virol. 2019 Jul 17;93(15):
pubmed: 31092580
FASEB J. 2018 Oct;32(10):5640-5646
pubmed: 29715048
Nat Rev Endocrinol. 2018 Feb;14(2):77-87
pubmed: 29052591

Auteurs

Gursimran K Dhamrait (GK)

Telethon Kids Institute, University of Western Australia, PO Box 855, West Perth, WA, 6782, Australia.

Kunjal Panchal (K)

Telethon Kids Institute, University of Western Australia, PO Box 855, West Perth, WA, 6782, Australia.

Naomi J Fleury (NJ)

Telethon Kids Institute, University of Western Australia, PO Box 855, West Perth, WA, 6782, Australia.

Tamara N Abel (TN)

Telethon Kids Institute, University of Western Australia, PO Box 855, West Perth, WA, 6782, Australia.

Mathew K Ancliffe (MK)

Telethon Kids Institute, University of Western Australia, PO Box 855, West Perth, WA, 6782, Australia.

Rachael C Crew (RC)

School of Human Sciences, University of Western Australia, Perth, WA, Australia.

Kevin Croft (K)

School of Biomedical Science - Royal Perth Hospital Unit, The University of Western Australia, Perth, WA, Australia.

Bernadette O Fernandez (BO)

Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK.

Magdalena Minnion (M)

Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK.

Prue H Hart (PH)

Telethon Kids Institute, University of Western Australia, PO Box 855, West Perth, WA, 6782, Australia.

Robyn M Lucas (RM)

National Centre for Epidemiology and Population Health, Research School of Population Health, Australian National University, Canberra, ACT, Australia.
Centre for Ophthalmology and Visual Science, University of Western Australia, Perth, WA, Australia.

Peter J Mark (PJ)

School of Human Sciences, University of Western Australia, Perth, WA, Australia.

Martin Feelisch (M)

Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton General Hospital, Southampton, UK.

Richard B Weller (RB)

MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, UK.

Vance Matthews (V)

School of Biomedical Science - Royal Perth Hospital Unit, The University of Western Australia, Perth, WA, Australia.

Shelley Gorman (S)

Telethon Kids Institute, University of Western Australia, PO Box 855, West Perth, WA, 6782, Australia. shelley.gorman@telethonkids.org.au.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH